Nivolumab+ipilimumab for first-line treatment of malignant pleural mesothelioma
Topic: Developments in Compensation for Mesothelioma: Immunotherapy and Home Renovation Cases
Keep up to date with Conference News & Alerts.
Receive the latest information about the International Mesothelioma Interest Group Meeting 2020 by entering your information below.
Now you will receive all the latest conference updates straight in your mailbox.